Taro Pharmaceutical Industries Ltd. (TARO) Position Trimmed by Teachers Advisors LLC

Teachers Advisors LLC trimmed its position in shares of Taro Pharmaceutical Industries Ltd. (NYSE:TARO) by 5.9% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 9,875 shares of the company’s stock after selling 620 shares during the period. Teachers Advisors LLC’s holdings in Taro Pharmaceutical Industries were worth $1,107,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently modified their holdings of TARO. River Road Asset Management LLC boosted its position in Taro Pharmaceutical Industries by 33.3% during the second quarter. River Road Asset Management LLC now owns 65,470 shares of the company’s stock worth $7,337,000 after purchasing an additional 16,350 shares during the period. Creative Planning boosted its position in Taro Pharmaceutical Industries by 3.8% during the second quarter. Creative Planning now owns 7,186 shares of the company’s stock worth $805,000 after purchasing an additional 265 shares during the period. Anchor Capital Advisors LLC boosted its position in Taro Pharmaceutical Industries by 0.4% during the second quarter. Anchor Capital Advisors LLC now owns 20,733 shares of the company’s stock worth $2,323,000 after purchasing an additional 77 shares during the period. Aperio Group LLC boosted its position in Taro Pharmaceutical Industries by 46.9% during the second quarter. Aperio Group LLC now owns 50,826 shares of the company’s stock worth $5,696,000 after purchasing an additional 16,233 shares during the period. Finally, Acadian Asset Management LLC boosted its position in Taro Pharmaceutical Industries by 19.0% during the second quarter. Acadian Asset Management LLC now owns 42,799 shares of the company’s stock worth $4,796,000 after purchasing an additional 6,824 shares during the period. Institutional investors and hedge funds own 14.20% of the company’s stock.

A number of research firms have commented on TARO. BidaskClub cut shares of Taro Pharmaceutical Industries from a “hold” rating to a “sell” rating in a research report on Friday, August 11th. TheStreet cut shares of Taro Pharmaceutical Industries from a “b-” rating to a “c+” rating in a research report on Wednesday, August 9th.

COPYRIGHT VIOLATION NOTICE: “Taro Pharmaceutical Industries Ltd. (TARO) Position Trimmed by Teachers Advisors LLC” was originally reported by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this story on another site, it was stolen and republished in violation of international copyright and trademark law. The legal version of this story can be viewed at https://sportsperspectives.com/2017/11/01/taro-pharmaceutical-industries-ltd-taro-position-trimmed-by-teachers-advisors-llc.html.

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) opened at 112.42 on Wednesday. Taro Pharmaceutical Industries Ltd. has a 52-week low of $92.28 and a 52-week high of $124.52. The company has a market capitalization of $4.55 billion, a PE ratio of 11.45 and a beta of 0.65. The firm’s 50-day moving average is $109.57 and its 200-day moving average is $110.43.

About Taro Pharmaceutical Industries

Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc (Taro Canada) and Taro U.SA The Company markets over 200 pharmaceutical products in over 25 countries.

Want to see what other hedge funds are holding TARO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Taro Pharmaceutical Industries Ltd. (NYSE:TARO).

Institutional Ownership by Quarter for Taro Pharmaceutical Industries (NYSE:TARO)

Receive News & Ratings for Taro Pharmaceutical Industries Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Taro Pharmaceutical Industries Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply